Concerns Expressed Over High Cost of Regenerative Medicines; As with Opdivo, “Bound to Become Issue Again”

Mr Chikazawa (left) and Mr Mohri A number of speakers expressed concerns over the high insurance reimbursement prices of regenerative medicines at a symposium on regenerative medicine products held by the Drug Information Association (DIA) in Tokyo on December 16...read more